Bloomington, IN and Merrimack, NH—Today, Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast® covered stent system, which recently received premarket approval for treatment of symptomatic iliac arterial occlusive disease. 
Cook Medical will assume sales, marketing and distribution rights for the product in the United States over the coming months. The iCast covered stent system will continue to be manufactured by Atrium Medical Corporation in Merrimack, NH, which is part of Getinge.
“This agreement with Cook Medical ensures that the iCast covered stent system will reach the optimum number of patients who will benefit from it in the United States,” said Patricia Fitch, president of Getinge NA. “This distribution agreement allows Getinge to best serve our U.S. market and accelerate our product innovation pipeline, which is in alignment with our global business strategy.”
“This product fills the need of a covered stent in our vascular portfolio with a proven technology. iCast has five-year data aligned with our commitment to long-term clinical evidence and predictable results for PAD Therapies,” said Mark Breedlove, senior vice president of Cook Medical’s Vascular division. “Our team is excited to support and distribute the iCast covered stent system across the U.S.”
Cook and Getinge continue to collaborate in other strategic areas, also partnering to complete the PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation IDE study with five-year follow up. The purpose of this study was to evaluate the safety and effectiveness of the Zenith Branch Endovascular Graft-Iliac Bifurcation in combination with the Atrium iCast covered stent in patients requiring treatment of aortoiliac and iliac aneurysms. Additional information about the clinical study is available at clinicaltrials.gov (NCT02571907).
ICast is a registered trademark of Atrium Medical Corporation.
About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people, today and tomorrow.
About Cook Medical
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today, we invent, manufacture and deliver a unique portfolio of medical devices to the healthcare systems of the world. Serving patients is a privilege, and we demand the highest standards of quality, ethics and service. We have remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.
Find out more at CookMedical.com and for the latest news, follow us on Twitter, Facebook and LinkedIn.
News coverage of this announcement
Endovascular Today—Cook Medical Will Distribute Getinge’s iCast Covered Stent System in the United States
Vascular News—Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Mass Device/Medical Tubing and Extrusion—Getinge, Cook Medical sign U.S. commercial distribution agreement for iCast covered stent
Vascular Specialist—Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Interventional News—Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Vascular Disease Management—Getinge and Cook Medical Enter Into Commercial Distribution Agreement for iCast Covered Stent System in the United States